HAP-FAST Feasibility Study
Key Points:
• Evaluating the clinical impact of low-dose CT scans and rapid molecular sputum analysis for suspected non-ventilator-associated hospital-acquired pneumonia (nv-HAP).
• Incorporating a pilot trial, qualitative study, costing analysis, and immune-pathophysiology investigation.
• Participants recruited from four acute hospitals in the Northwest of the UK.
• Assessing trial processes, outcome measures, and patient/staff experiences to determine feasibility of a future trial.
Practical Solutions and Value:
• Utilizing AI-driven platform DocSym to consolidate ICD-11 standards, clinical protocols, and research for clinicians.
• Streamlining operations with mobile apps for scheduling, treatment monitoring, and telemedicine to enhance patient care and expand digital services.
• AI integration to improve workflows and patient outcomes while reducing paper routines.
• Learn more at aidevmd.com.